Spero Therapeutics (SPRO) Other Non-Current Liabilities (2016 - 2022)
Spero Therapeutics (SPRO) posted Other Non-Current Liabilities of $100,000 for Q3 2022, unchanged from the prior quarter.
Powered by 
Analysis
Spero Therapeutics (SPRO) Other Non-Current Liabilities (2016 - 2022) Analysis & Trends
At the end of FY2021, Spero Therapeutics' Other Non-Current Liabilities came in at $802,000.
- Annual Other Non-Current Liabilities shows a five-year compound annual growth rate of 10.2% (FY2016 to FY2021).
- In prior years, Spero Therapeutics' Other Non-Current Liabilities was $833,000 in FY2018 (+128.2%) and $365,000 in FY2017 (-26.0%).
- Quarterly Other Non-Current Liabilities has run from a low of $100,000 in Q2 2022 to a high of $1 million in Q1 2022 over five years.
- The strongest year-over-year quarter for Other Non-Current Liabilities in the past five years was Q4 2018, with growth of 128.2%; the weakest was Q2 2019, with a decline of 38.1%.
- According to Business Quant data, Other Non-Current Liabilities for the three prior quarters was $100,000 (Q2 2022), $1 million (Q1 2022) and $802,000 (Q4 2021).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Spero Therapeutics | 58.73 Mn | -137.06 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2022 | 100,000.00 |
| Jun 30, 2022 | 100,000.00 |
| Mar 31, 2022 | 1.00 Mn |
| Dec 31, 2021 | 802,000.00 |
| Mar 31, 2020 | 200,000.00 |
| Sep 30, 2019 | 200,000.00 |
| Jun 30, 2019 | 200,000.00 |
| Mar 31, 2019 | 223,000.00 |
| Dec 31, 2018 | 833,000.00 |
| Sep 30, 2018 | 290,000.00 |
| Jun 30, 2018 | 323,000.00 |
| Mar 31, 2018 | 327,000.00 |
| Dec 31, 2017 | 365,000.00 |
| Sep 30, 2017 | 399,000.00 |
| Jun 30, 2017 | 200,000.00 |
| Dec 31, 2016 | 493,000.00 |
| Sep 30, 2016 | 2.71 Mn |
API Access
Spero Therapeutics Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=SPRO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "SPRO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=SPRO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();